Cheetah Medical

Noninvasive Fluid Management Technologies

Health Tech & Life Sciences
Acquired (Inactive) by Baxter International on Sep 2019 - closed due to acquisition

Company Overview

Snapshot

Founded in March 2000, Cheetah Medical operated with 11–50 employees, developing noninvasive fluid management technologies. The company raised a total of $99.11 million across 8 funding rounds from 10 investors before being acquired by Baxter International in September 2019.

Business overview

Cheetah Medical specialized in noninvasive fluid management technologies for critical care, operating room, and emergency department settings. Its core products, the CHEETAH NICOM and Starling SV systems, utilized a proprietary algorithm to calculate hemodynamic parameters, enabling medical professionals to make informed treatment decisions for optimal fluid volume and organ perfusion. The company served the healthcare industry, particularly hospitals, across various global markets including the United States, Asia, and Europe, operating within the Health Tech & Life Sciences sector.

Strategic signal

The acquisition of Cheetah Medical by Baxter International in September 2019 for $190 million marked a significant strategic move, integrating Cheetah's noninvasive fluid management technologies into a larger medical device portfolio. This acquisition validated the market need for advanced hemodynamic monitoring solutions and signaled a consolidation trend within the health tech sector, aiming to enhance patient outcomes and economic efficiencies through comprehensive critical care offerings.

Company Intelligence Q&A

When was Cheetah Medical acquired?
Cheetah Medical was acquired by Baxter International in September 2019.
What was the acquisition amount for Cheetah Medical?
Baxter International acquired Cheetah Medical for $190 million in September 2019.
Which investors participated in Cheetah Medical's September 2017 funding round?
In September 2017, Cheetah Medical received funding from Springfield Capital Management and MVM Life Science Partners.
What was the strategic focus of Cheetah Medical's partnership with Sepsis Alliance?
In March 2019, Cheetah Medical partnered with Sepsis Alliance to support healthcare provider education on sepsis, a leading cause of death in the United States.
What new solutions did Cheetah Medical launch in March 2019?
In March 2019, Cheetah Medical launched a Rapid Response Team Solution and a new user interface for its systems.

External links